Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Phathom: 3 Key Takeaways for Long-Term Investors

Back-to-back quarters of operating profit show the company is converting revenue growth into cash, a milestone that matters for debt covenants and financial sustainability.

  • Phathom reported $84.7 million in net revenues for Q3 2026, a 71% year-over-year growth.
  • The company is expanding VOQUEZNA coverage through physician education and $0 copay via BlinkRx.
  • Phathom achieved operating profitability and positive cash flow for two consecutive quarters.

More from Wednesday 18 November →